STOCK TITAN

PTC Therapeutics to Participate at 42nd Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
PTC Therapeutics, Inc. (NASDAQ: PTCT) will present a company overview at the 42nd Annual J.P. Morgan Healthcare Conference on Jan. 8, 2024. The presentation will be webcast live on the company's website and archived for 30 days.
Positive
  • None.
Negative
  • None.

SOUTH PLAINFIELD, N.J., Jan. 3, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will present a company overview at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, Jan. 8, at 7:30 a.m. PST/10:30 a.m. EST.

The presentations will be webcast live on the Events and Presentations page under the Investor section of PTC Therapeutics' website at https://ir.ptcbio.com/events-presentations and will be archived for 30 days following the presentations. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection. 

About PTC Therapeutics, Inc.

PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need. The Company's strategy is to leverage its strong scientific expertise and global commercial infrastructure to maximize value for its patients and other stakeholders. To learn more about PTC, please visit us at www.ptcbio.com and follow us on Instagram, Facebook, Twitter, and LinkedIn.

For More Information:

Investors:
Kylie O'Keefe
+1 (908) 300-0691
kokeefe@ptcbio.com

Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com

Cision View original content:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-participate-at-42nd-annual-jp-morgan-healthcare-conference-302024767.html

SOURCE PTC Therapeutics

FAQ

When will PTC Therapeutics, Inc. present at the 42nd Annual J.P. Morgan Healthcare Conference?

PTC Therapeutics, Inc. will present at the conference on Monday, Jan. 8, 2024 at 7:30 a.m. PST/10:30 a.m. EST.

Where can I watch the live webcast of the presentation?

The live webcast will be available on the Events and Presentations page under the Investor section of PTC Therapeutics' website at https://ir.ptcbio.com/events-presentations.

How long will the webcast be available for viewing?

The webcast will be archived for 30 days following the presentation.

What should users do before the webcast to ensure a timely connection?

It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection.

PTC Therapeutics, Inc.

NASDAQ:PTCT

PTCT Rankings

PTCT Latest News

PTCT Stock Data

2.44B
56.48M
2.79%
112.93%
13.39%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
SOUTH PLAINFIELD

About PTCT

ptc is biopharmaceutical company focused on the discovery and development of orally-administered, proprietary small molecule drugs that target post-transcriptional control processes. while ptc’s discovery programs are directed at targets in multiple therapeutic areas, ptc is focusing particularly on the development and commercialization of treatments for orphan and ultra-orphan disorders. post-transcriptional control processes regulate the rate and timing of protein production and are essential to proper cellular function. ptc’s internally-discovered pipeline addresses multiple therapeutic areas, including neuromuscular disorders, oncology and infectious diseases. for more information on the company, please visit our website www.ptcbio.com.